Skip to main content

Table 5 Crude incidence rate estimates of key B-cell malignancies: aggregate rates by country, race, and ethnicity

From: Cytomegalovirus infection may be oncoprotective against neoplasms of B-lymphocyte lineage: single-institution experience and survey of global evidence

Country

(race/ethnicity)

Lymphoid malignancy

(crude annual incidence estimates/105 population)

Summed crude aggregate estimates

B-NHL*

HD

B-ALL

B-CLL

PCM

The US

27.4

3.23

1.69

6.3

6.1

44.72

The US-born Asians

11.8

1.28

0.7

1.8

3.2

18.6

Europe

(wgt. mean)

11.6

3.58

0.68

4.88

4.7

25.44

Middle East

4.9

1.45

0.56

0.71

1.5

9.12

Sub-Saharan Africa

5.5

0.7

0.35

0.36

0.29

7.2

Hong Kong

6.68

0.62

1.28

0.6

2.31

11.49

East Asia (China, Japan)

4.8

0.53

0.96

1.13

1.3

8.72

  1. *B-NHL B-cell non-Hodgkin Lymphoma; HD Hodgkin’s disease; B-ALL B-cell acute lymphoblastic leukemia; B-CLL B-cell chronic lymphocytic leukemia; PCM plasma cell myeloma
Back to article page

Virology Journal

ISSN: 1743-422X